Torres-Quispe Percy, Fernández-Rodríguez Lissett Jeanette, Zhang Yaowen, Rovirosa-Casino Angeles
Department of Oncology and Radiotherapy, Hospital Nacional Edgardo Rebagliati Martins, Av. Edgardo Rebagliati 490, Jesús María, Lima 15072, Perú.
Universidad Nacional San Antonio Abad del Cusco, Av. de La Cultura 773, Cusco 08000, Perú.
Ecancermedicalscience. 2021 Sep 30;15:1297. doi: 10.3332/ecancer.2021.1297. eCollection 2021.
Lip cancer (LC) is the most common cancer of the oral cavity and is the second most common in the head and neck. Brachytherapy (BT) is a good treatment option for this type of cancer because it administers high doses of radiation to the target. BT has similar cure and survival rates as surgery for the same type of cancer, but it often produces more favourable aesthetic results, especially when the tumour is treated in its early stages. We present a case of a patient diagnosed with stage II lower LC who refused surgical treatment. Instead, high-dose-rate interstitial BT was performed with Ir. A 2-year post-treatment follow-up indicated there were neither serious complications nor recurrence of cancer during that period.
唇癌(LC)是口腔最常见的癌症,在头颈部癌症中位列第二。近距离放射治疗(BT)是这类癌症的一种良好治疗选择,因为它能向靶区给予高剂量辐射。对于同一类型的癌症,BT的治愈率和生存率与手术相似,但它通常能产生更理想的美学效果,尤其是在肿瘤早期进行治疗时。我们报告一例被诊断为II期下唇癌的患者,该患者拒绝手术治疗。取而代之的是,使用铱进行了高剂量率组织间BT。治疗后2年的随访表明,在此期间既没有严重并发症,也没有癌症复发。